A second hotspot for pathogenic exon-skipping variants in CDC45.


Journal

European journal of human genetics : EJHG
ISSN: 1476-5438
Titre abrégé: Eur J Hum Genet
Pays: England
ID NLM: 9302235

Informations de publication

Date de publication:
11 Mar 2024
Historique:
received: 16 12 2023
accepted: 26 02 2024
revised: 13 02 2024
medline: 12 3 2024
pubmed: 12 3 2024
entrez: 12 3 2024
Statut: aheadofprint

Résumé

Biallelic pathogenic variants in CDC45 are associated with Meier-Gorlin syndrome with craniosynostosis (MGORS type 7), which also includes short stature and absent/hypoplastic patellae. Identified variants act through a hypomorphic loss of function mechanism, to reduce CDC45 activity and impact DNA replication initiation. In addition to missense and premature termination variants, several pathogenic synonymous variants have been identified, most of which cause increased exon skipping of exon 4, which encodes an essential part of the RecJ-orthologue's DHH domain. Here we have identified a second cohort of families segregating CDC45 variants, where patients have craniosynostosis and a reduction in height, alongside common facial dysmorphisms, including thin eyebrows, consistent with MGORS7. Skipping of exon 15 is a consequence of two different variants, including a shared synonymous variant that is enriched in individuals of East Asian ancestry, while other variants in trans are predicted to alter key intramolecular interactions in α/β domain II, or cause retention of an intron within the 3'UTR. Our cohort and functional data confirm exon skipping is a relatively common pathogenic mechanism in CDC45, and highlights the need for alternative splicing events, such as exon skipping, to be especially considered for variants initially predicted to be less likely to cause the phenotype, particularly synonymous variants.

Identifiants

pubmed: 38467731
doi: 10.1038/s41431-024-01583-1
pii: 10.1038/s41431-024-01583-1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS)
ID : U01HG007672
Organisme : U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS)
ID : U01HG007672

Informations de copyright

© 2024. The Author(s).

Références

Bellelli R, Boulton SJ. Spotlight on the replisome: aetiology of DNA replication-associated genetic diseases. Trends Genet. 2021;37:317–36.
doi: 10.1016/j.tig.2020.09.008 pubmed: 33041047
Yuan Z, Bai L, Sun J, Georgescu R, Liu J, O’Donnell ME, et al. Structure of the eukaryotic replicative CMG helicase suggests a pumpjack motion for translocation. Nat Struct Mol Biol. 2016;23:217–24.
doi: 10.1038/nsmb.3170 pubmed: 26854665 pmcid: 4812828
Hashimoto Y, Sadano K, Miyata N, Ito H, Tanaka H. Novel role of DONSON in CMG helicase assembly during vertebrate DNA replication initiation. EMBO J. 2023;42:e114131.
doi: 10.15252/embj.2023114131 pubmed: 37458194
Kingsley G, Skagia A, Passaretti P, Fernandez-Cuesta C, Reynolds-Winczura A, Koscielniak K, et al. DONSON facilitates Cdc45 and GINS chromatin association and is essential for DNA replication initiation. Nucleic Acids Res. 2023;51:9748–63.
doi: 10.1093/nar/gkad694 pubmed: 37638758 pmcid: 10570026
Lim Y, Tamayo-Orrego L, Schmid E, Tarnauskaite Z, Kochenova OV, Gruar R, et al. In silico protein interaction screening uncovers DONSON’s role in replication initiation. Science. 2023;381:eadi3448.
doi: 10.1126/science.adi3448 pubmed: 37590370 pmcid: 10801813
Nielsen-Dandoroff E, Ruegg MSG, Bicknell LS. The expanding genetic and clinical landscape associated with Meier-Gorlin syndrome. Eur J Hum Genet. 2023;31:859–68.
doi: 10.1038/s41431-023-01359-z pubmed: 37059840 pmcid: 10400559
Fenwick AL, Kliszczak M, Cooper F, Murray J, Sanchez-Pulido L, Twigg SR, et al. Mutations in CDC45, encoding an essential component of the pre-initiation complex, cause meier-gorlin syndrome and craniosynostosis. Am J Hum Genet. 2016;99:125–38.
doi: 10.1016/j.ajhg.2016.05.019 pubmed: 27374770 pmcid: 5005452
Knapp KM, Fellows B, Aggarwal S, Dalal A, Bicknell LS. A synonymous variant in a non-canonical exon of CDC45 disrupts splicing in two affected sibs with Meier-Gorlin syndrome with craniosynostosis. Eur J Med Genet. 2021;64:104182.
doi: 10.1016/j.ejmg.2021.104182 pubmed: 33639314
Li X, Zhang LZ, Yu L, Long ZL, Lin AY, Gou CY. Prenatal diagnosis of Meier-Gorlin syndrome 7: a case presentation. BMC Pregnancy Childbirth. 2021;21:381.
doi: 10.1186/s12884-021-03868-5 pubmed: 34000999 pmcid: 8130261
Ting CY, Bhatia NS, Lim JY, Goh CJ, Vasanwala RF, Ong CC, et al. Further delineation of CDC45-related Meier-Gorlin syndrome with craniosynostosis and review of literature. Eur J Med Genet. 2020;63:103652.
doi: 10.1016/j.ejmg.2019.04.009 pubmed: 30986546
Kishore S, Khanna A, Stamm S. Rapid generation of splicing reporters with pSpliceExpress. Gene. 2008;427:104–10.
doi: 10.1016/j.gene.2008.09.021 pubmed: 18930792 pmcid: 2821805
Sievers F, Wilm A, Dineen D, Gibson TJ, Karplus K, Li W, et al. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol. 2011;7:539.
doi: 10.1038/msb.2011.75 pubmed: 21988835 pmcid: 3261699
Waterhouse AM, Procter JB, Martin DM, Clamp M, Barton GJ. Jalview Version 2–a multiple sequence alignment editor and analysis workbench. Bioinformatics. 2009;25:1189–91.
doi: 10.1093/bioinformatics/btp033 pubmed: 19151095 pmcid: 2672624
Simon AC, Sannino V, Costanzo V, Pellegrini L. Structure of human Cdc45 and implications for CMG helicase function. Nat Commun. 2016;7:11638.
doi: 10.1038/ncomms11638 pubmed: 27189187 pmcid: 4873980
Liu HX, Zhang M, Krainer AR. Identification of functional exonic splicing enhancer motifs recognized by individual SR proteins. Genes Dev. 1998;12:1998–2012.
doi: 10.1101/gad.12.13.1998 pmcid: 316967
Fu XD, Mayeda A, Maniatis T, Krainer AR. General splicing factors SF2 and SC35 have equivalent activities in vitro, and both affect alternative 5’ and 3’ splice site selection. Proc Natl Acad Sci USA. 1992;89:11224–8.
doi: 10.1073/pnas.89.23.11224 pubmed: 1454802 pmcid: 50522
Pollard KS, Hubisz MJ, Rosenbloom KR, Siepel A. Detection of nonneutral substitution rates on mammalian phylogenies. Genome Res. 2010;20:110–21.
doi: 10.1101/gr.097857.109 pubmed: 19858363 pmcid: 2798823
Jaganathan K, Kyriazopoulou Panagiotopoulou S, McRae JF, Darbandi SF, Knowles D, Li YI, et al. Predicting splicing from primary sequence with deep learning. Cell. 2019;176:535–48.e24.
doi: 10.1016/j.cell.2018.12.015 pubmed: 30661751
Chui MH, Yang C, Mehta N, Rai V, Zehir A, Momeni Boroujeni A, et al. Somatic intronic TP53 c.375+5G mutations are a recurrent but under-recognized mode of TP53 inactivation. J Pathol Clin Res. 2022;8:14–8.
doi: 10.1002/cjp2.242 pubmed: 34505757
Dalphin ME, Stockwell PA, Tate WP, Brown CM. TransTerm, the translational signal database, extended to include full coding sequences and untranslated regions. Nucleic Acids Res. 1999;27:293–4.
doi: 10.1093/nar/27.1.293 pubmed: 9847206 pmcid: 148161
Fallmann J, Sedlyarov V, Tanzer A, Kovarik P, Hofacker IL. AREsite2: an enhanced database for the comprehensive investigation of AU/GU/U-rich elements. Nucleic Acids Res. 2016;44:D90–5.
doi: 10.1093/nar/gkv1238 pubmed: 26602692
Biswas A, Brown CM. Scan for Motifs: a webserver for the analysis of post-transcriptional regulatory elements in the 3’ untranslated regions (3’ UTRs) of mRNAs. BMC Bioinforma. 2014;15:174.
doi: 10.1186/1471-2105-15-174
Siegel DA, Le Tonqueze O, Biton A, Zaitlen N, Erle DJ. Massively parallel analysis of human 3’ UTRs reveals that AU-rich element length and registration predict mRNA destabilization. G3 (Bethesda). 2022;12:jkab404.
Guarracino A, Pepe G, Ballesio F, Adinolfi M, Pietrosanto M, Sangiovanni E, et al. BRIO: a web server for RNA sequence and structure motif scan. Nucleic Acids Res. 2021;49:W67–W71.
doi: 10.1093/nar/gkab400 pubmed: 34038531 pmcid: 8262756
Hogg JR, Goff SP. Upf1 senses 3’UTR length to potentiate mRNA decay. Cell. 2010;143:379–89.
doi: 10.1016/j.cell.2010.10.005 pubmed: 21029861 pmcid: 2981159
Mariella E, Marotta F, Grassi E, Gilotto S, Provero P. The length of the expressed 3’ UTR is an intermediate molecular phenotype linking genetic variants to complex diseases. Front Genet. 2019;10:714.
doi: 10.3389/fgene.2019.00714 pubmed: 31475030 pmcid: 6707137
Cheng K, Xu H, Chen X, Wang L, Tian B, Zhao Y, et al. Structural basis for DNA 5 -end resection by RecJ. Elife. 2016;5:e14294.
doi: 10.7554/eLife.14294 pubmed: 27058167 pmcid: 4846377
Gelfman S, Wang Q, McSweeney KM, Ren Z, La Carpia F, Halvorsen M, et al. Annotating pathogenic non-coding variants in genic regions. Nat Commun. 2017;8:236.
doi: 10.1038/s41467-017-00141-2 pubmed: 28794409 pmcid: 5550444
Rhine CL, Neil C, Wang J, Maguire S, Buerer L, Salomon M, et al. Massively parallel reporter assays discover de novo exonic splicing mutants in paralogs of Autism genes. PLoS Genet. 2022;18:e1009884.
doi: 10.1371/journal.pgen.1009884 pubmed: 35051175 pmcid: 8775188
Vihinen M. When a synonymous variant is nonsynonymous. Genes (Basel). 2022;13:1485.
Walker LC, Hoya M, Wiggins GAR, Lindy A, Vincent LM, Parsons MT, et al. Using the ACMG/AMP framework to capture evidence related to predicted and observed impact on splicing: recommendations from the ClinGen SVI Splicing Subgroup. Am J Hum Genet. 2023;110:1046–67.
doi: 10.1016/j.ajhg.2023.06.002 pubmed: 37352859 pmcid: 10357475
Pechmann S, Frydman J. Evolutionary conservation of codon optimality reveals hidden signatures of cotranslational folding. Nat Struct Mol Biol. 2013;20:237–43.
doi: 10.1038/nsmb.2466 pubmed: 23262490
Presnyak V, Alhusaini N, Chen YH, Martin S, Morris N, Kline N, et al. Codon optimality is a major determinant of mRNA stability. Cell. 2015;160:1111–24.
doi: 10.1016/j.cell.2015.02.029 pubmed: 25768907 pmcid: 4359748
Zeng Z, Bromberg Y. Predicting functional effects of synonymous variants: a systematic review and perspectives. Front Genet. 2019;10:914.
doi: 10.3389/fgene.2019.00914 pubmed: 31649718 pmcid: 6791167
Cartegni L, Chew SL, Krainer AR. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet. 2002;3:285–98.
doi: 10.1038/nrg775 pubmed: 11967553
Sauna ZE, Kimchi-Sarfaty C. Understanding the contribution of synonymous mutations to human disease. Nat Rev Genet. 2011;12:683–91.
doi: 10.1038/nrg3051 pubmed: 21878961
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24.
doi: 10.1038/gim.2015.30 pmcid: 4544753
Park E, Pan Z, Zhang Z, Lin L, Xing Y. The expanding landscape of alternative splicing variation in human populations. Am J Hum Genet. 2018;102:11–26.
doi: 10.1016/j.ajhg.2017.11.002 pubmed: 29304370 pmcid: 5777382

Auteurs

Kelly Schoch (K)

Division of Medical Genetics, Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA.

Mischa S G Ruegg (MSG)

Department of Biochemistry, University of Otago, Dunedin, New Zealand.

Bridget J Fellows (BJ)

Department of Biochemistry, University of Otago, Dunedin, New Zealand.

Joseph Cao (J)

Division of Pediatric Radiology, Department of Radiology Duke University School of Medicine, Durham, NC, USA.

Sabine Uhrig (S)

Institute of Clinical Genetics, Klinikum Stuttgart, Stuttgart, Germany.

Stephanie Einsele-Scholz (S)

Center for Human Genetics Tuebingen and CeGaT GmbH, Tuebingen, Germany.

Saskia Biskup (S)

Center for Human Genetics Tuebingen and CeGaT GmbH, Tuebingen, Germany.

Samuel R A Hawarden (SRA)

Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.

Vincenzo Salpietro (V)

Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.

Valeria Capra (V)

Genomics and Clinical Genetics, IRCCS Istituto Giannina Gaslini, Genoa, Italy.

Chris M Brown (CM)

Department of Biochemistry, University of Otago, Dunedin, New Zealand.

Andrea Accogli (A)

Department of Specialized Medicine, Division of Medical Genetics, McGill University Health Centre, Montreal, QC, Canada.
Department of Human Genetics, Faculty of Medicine, McGill University, Montreal, QC, Canada.

Vandana Shashi (V)

Division of Medical Genetics, Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA.

Louise S Bicknell (LS)

Department of Biochemistry, University of Otago, Dunedin, New Zealand. louise.bicknell@otago.ac.nz.

Classifications MeSH